Cleavage of type i collagen by fibroblast activation protein-α enhances class a scavenger receptor mediated macrophage adhesion

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Mazur, Anna ^a   Holthoff, Emily ^a   Vadali, Shanthi ^b   Kelly, Thomas ^b   Post, Steven R ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; INTEGRIN; SCAVENGER RECEPTOR A; SEPRASE; GELATINASE; MEMBRANE PROTEIN; RECOMBINANT PROTEIN; SERINE PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CELL ADHESION; CONTROLLED STUDY; FEMALE; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ANIMAL; BREAST; C57BL MOUSE; CELL CULTURE; CYTOLOGY; HUMAN; MACROPHAGE; METABOLISM; PATHOLOGY;

ANIMALS; BREAST; BREAST NEOPLASMS; CELL ADHESION; CELLS, CULTURED; COLLAGEN TYPE I; FEMALE; GELATINASES; HUMANS; INTEGRINS; MACROPHAGES; MEMBRANE PROTEINS; MICE, INBRED C57BL; RECOMBINANT PROTEINS; SCAVENGER RECEPTORS, CLASS A; SERINE ENDOPEPTIDASES;

EID: 84961137837     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150287     Document Type: Article

References (63)

1. Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012; 196(4):395-406. doi: 10.1083/jcb.201102147 PMID: 22351925; PubMed Central PMCID: PMC3283993.
2. Cox TR, Bird D, Baker AM, Barker HE, Ho MW, Lang G, et al. LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res. 2013; 73(6):1721-32. Epub 2013/01/25. doi: 10.1158/0008-5472.CAN-12-2233 PMID: 23345161; PubMed Central PMCID: PMC3672851.
3. Ng MR, Brugge JS. A stiff blow from the stroma: collagen crosslinking drives tumor progression. Cancer Cell. 2009; 16(6):455-7. Epub 2009/12/08. doi: 10.1016/j.ccr.2009.11.013 PMID: 19962663.
4. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139(5):891-906. Epub 2009/11/26. doi: 10.1016/j. cell.2009.10.027 PMID: 19931152; PubMed Central PMCID: PMC2788004.
5. Devy L, Huang L, Naa L, Yanamandra N, Pieters H, Frans N, et al. Selective inhibition of matrix metallo-proteinase-14 blocks tumor growth, invasion, andangiogenesis. Cancer Res. 2009; 69(4):1517-26. Epub 2009/02/12. doi: 10.1158/0008-5472.CAN-08-3255 PMID: 19208838.
6. Taniwaki K, Fukamachi H, Komori K, Ohtake Y, Nonaka T, Sakamoto T, et al. Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice. Cancer Res. 2007; 67(9):4311-9. Epub 2007/05/08. doi: 10.1158/0008-5472.CAN-06-4761 PMID: 17483344.
7. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006; 6(5):392-401. doi: 10.1038/nrc1877 PMID: 16572188.
8. Scanlan MJ, Raj BK, Calvo B, Garin-Chesa P, Sanz-Moncasi MP, Healey JH, et al. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci USA. 1994; 91(12):5657-61. Epub 1994/06/07. PMID: 7911242; PubMed Central PMCID: PMC44055.
9. Huber MA, Kraut N, Park JE, Schubert RD, Rettig WJ, Peter RU, et al. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. J Invest Dermatol. 2003; 120(2):182-8. Epub 2003/01/25. doi: 10.1046/j.1523-1747.2003. 12035.x PMID: 12542520.
10. Rosenblum JS, Kozarich JW. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery. Current opinion in chemical biology. 2003; 7(4):496-504. doi: 10.1016/S1367-5931(03) 00084-X PMID: 12941425.
11. Kelly T. Evaluation of seprase activity. Clinical & experimental metastasis. 1999; 17(1):57-62. Epub 1999/07/02. PMID: 10390148.
12. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem. 1999; 274(51):36505-12. PMID: 10593948.
13. Brokopp CE, Schoenauer R, Richards P, Bauer S, Lohmann C, Emmert MY, et al. Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata. Eur Heart J. 2011; 32(21):2713-22. Epub 2011/02/05. doi: 10.1093/eurheartj/ehq519 PMID: 21292680; PubMed Central PMCID: PMC3205479.
14. Levy MT, Mc Caughan GW, Abbott CA, Park JE, Cunningham AM, Muller E, et al. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology. 1999; 29(6):1768-78. Epub 1999/05/29. doi: 10. 1002/hep.510290631 PMID: 10347120.
15. Comito G, Giannoni E, Segura CP, Barcellos-de-Souza P, Raspollini MR, Baroni G, et al. Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression. Oncogene. 2014; 33(19):2423-31. Epub 2013/06/04. doi: 10.1038/onc.2013.191 PMID: 23728338.
16. Hao NB, Lu MH, Fan YH, Cao YL, Zhang ZR, Yang SM. Macrophages in tumor microenvironments and the progression of tumors. Clinical & developmental immunology. 2012; 2012:948098. doi: 10.1155/2012/948098 PMID: 22778768; PubMed Central PMCID: PMC3385963.
17. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer research. 2006; 66(2):605-12. Epub 2006/01/21. doi: 10.1158/0008-5472.CAN-05-4005 PMID: 16423985.
18. Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep. 2005; 14(2):425-31. Epub 2005/07/14. PMID: 16012726.
19. Koyama Y, Norose-Toyoda K, Hirano S, Kobayashi M, Ebihara T, Someki I, et al. Type I collagen is a non-adhesive extracellular matrix for macrophages. Arch Histol Cytol. 2000; 63(1):71-9. Epub 2000/04/19. PMID: 10770590.
20. Gowen BB, Borg TK, Ghaffar A, Mayer EP. Selective adhesion of macrophages to denatured forms of type I collagen is mediated by scavenger receptors. Matrix Biology. 2000; 19(1):61-71. PMID: 10686426
21. Thomas DW, O'Neill ID, Harding KG, Shepherd JP. Cutaneous wound healing: a current perspective. Journal of oral and maxillofacial surgery: official journal of the American Association of Oral and Maxillofacial Surgeons. 1995; 53(4):442-7. Epub 1995/04/01. PMID: 7699500.
22. Nikolic DM, Cholewa J, Gass C, Gong MC, Post SR. Class A scavenger receptor-mediated cell adhesion requires the sequential activation of Lyn and PI3-kinase. Am J Physiol Cell Physiol. 2007; 292(4): C1450-8. Epub 2006/12/29. doi: 10.1152/ajpcell.00401.2006 PMID: 17192284.
23. Nikolic DM, Gong MC, Turk J, Post SR. Class A scavenger receptor-mediated macrophage adhesion requires coupling of calcium-independent phospholipaseA(2) and 12/15-lipoxygenaseto Racand Cdc42 activation. J Biol Chem. 2007; 282(46):33405-11. Epub 2007/09/18. doi: 10.1074/jbc. M704133200 PMID: 17873277; PubMed Central PMCID: PMC2080787.
24. Kirkham PA, Spooner G, Ffoulkes-Jones C, Calvez R. Cigarette smoke triggers macrophage adhesion and activation: role of lipid peroxidation products and scavenger receptor. Free radical biology & medicine. 2003; 35(7):697-710. Epub 2003/10/30. doi: 10.1016/S0891-5849(03)00390-3 PMID: 14583334.
25. El Khoury J, Thomas CA, Loike JD, Hickman SE, Cao L, Silverstein SC. Macrophages adhere to glucose-modified basement membrane collagen IV via their scavenger receptors. J Biol Chem. 1994; 269 (14):10197-200. PMID: 8144597
26. Qu A, Leahy DJ. The role of the divalent cation in the structure of the I domain from the CD11a/CD18 integrin. Structure. 1996; 4(8):931-42. Epub 1996/08/15. PMID: 8805579.
27. Fraser I, Hughes D, Gordon S. Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature. 1993; 364(6435):343-6. PMID: 8332192
28. Post SR, Gass C, Rice S, Nikolic D, Crump H, Post GR. Class A scavenger receptors mediate cell adhesion via activation of G(i/o) and formation of focal adhesion complexes. J Lipid Res. 2002; 43 (11):1829-36. Epub 2002/10/29. PMID: 12401881.
29. Zhang K, Chen J. The regulation of integrin function by divalent cations. Cell Adh Migr. 2012; 6(1):20-9. doi: 10.4161/cam.18702 PMID: 22647937; PubMed Central PMCID: PMC3364134.
30. Santiago-Garcia J, Kodama T, Pitas RE. The class A scavenger receptor binds to proteoglycans and mediates adhesion of macrophages to the extracellular matrix. J Biol Chem. 2003; 278(9):6942-6. Epub 2002/12/19. doi: 10.1074/jbc.M208358200 PMID: 12488451.
31. Lysko PG, Weinstock J, Webb CL, Brawner ME, Elshourbagy NA. Identification of a small-molecule, nonpeptide macrophage scavenger receptor antagonist. J Pharmacol Exp Ther. 1999; 289(3):1277-85. Epub 1999/05/21. PMID: 10336517.
32. Santos AM, Jung J, Aziz N, Kissil JL, Pure E. Targeting fibroblast activation protein inhibits tumor stro-magenesis and growth in mice. J Clin Invest. 2009; 119(12):3613-25. Epub 2009/11/19. doi: 10.1172/JCI38988 PMID: 19920354; PubMed Central PMCID: PMC2786791.
33. Kelly T, Huang Y, Simms AE, Mazur A. Fibroblast activation protein-alpha: a key modulator of the microenvironment in multiple pathologies. International review of cell and molecular biology. 2012; 297:83-116. doi: 10.1016/B978-0-12-394308-8.00003-0 PMID: 22608558.
34. Cohen SJ, Alpaugh RK, Palazzo I, Meropol NJ, Rogatko A, Xu Z, et al. Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma. Pancreas. 2008; 37(2):154-8. Epub 2008/07/31. doi: 10.1097/MPA.0b013e31816618ce PMID: 18665076.
35. Iwasa S, Okada K, Chen WT, Jin X, Yamane T, Ooi A, et al. 'Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer'. Cancer Lett. 2005; 227(2):229-36. Epub 2005/10/01. PMID: 16196122.
36. Mikheeva SA, Mikheev AM, Petit A, Beyer R, Oxford RG, Khorasani L, et al. TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol Cancer. 2010; 9:194. Epub 2010/07/22. doi: 10.1186/1476-4598-9-194 PMID: 20646316; PubMed Central PMCID: PMC2920263.
37. Garin-Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci USA. 1990; 87(18):7235-9. PMID: 2402505; PubMed Central PMCID: PMCPMC54718.
38. Niedermeyer J, Scanlan MJ, Garin-Chesa P, Daiber C, Fiebig HH, Old LJ, et al. Mouse fibroblast activation protein: molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancers. Int J Cancer. 1997;71(3):383-9. PMID: 9139873.
39. Lee HO, Mullins SR, Franco-Barraza J, Valianou M, Cukierman E, Cheng JD. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells. BMC cancer. 2011; 11:245. Epub 2011/06/15. doi: 10.1186/1471-2407-11-245 PMID: 21668992; PubMed Central PMCID: PMC3141768.
40. Liao D, Luo Y, Markowitz D, Xiang R, Reisfeld RA. Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model. Plo Sone. 2009; 4(11):e7965. Epub 2009/12/04. doi: 10.1371/journal.pone.0007965 PMID: 19956757; PubMed Central PMCID: PMC2775953.
41. Gown AM, Tsukada T, Ross R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol. 1986; 125(1):191-207. Epub 1986/10/01. PMID: 3777135; PubMed Central PMCID: PMC1888443.
42. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993; 362 (6423):801-9. Epub 1993/04/29. doi: 10.1038/362801a0 PMID: 8479518.
43. Hirata K, Shikata K, Matsuda M, Akiyama K, Sugimoto H, Kushiro M, et al. Increased expression of selectins in kidneys of patients with diabetic nephropathy. Diabetologia. 1998; 41(2):185-92. Epub 1998/03/14. doi: 10.1007/s001250050888 PMID: 9498652.
44. Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, et al. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes. 2003; 52(10):2586-93. Epub 2003/09/30. PMID: 14514644.
45. Novak ML, Koh TJ. Phenotypic transitions of macrophages orchestrate tissue repair. Am J Pathol. 2013; 183(5):1352-63. doi: 10.1016/j.ajpath.2013.06.034 PMID: 24091222; PubMed Central PMCID: PMC3969506.
46. Novak ML, Koh TJ. Macrophage phenotypes during tissue repair. J Leukoc Biol. 2013; 93(6):875-81. doi: 10.1189/jlb.1012512 PMID: 23505314; PubMed Central PMCID: PMC3656331.
47. Weidenbusch M, Anders HJ. Tissue microenvironments define and get reinforced by macrophage phenotypes in homeostasis or during inflammation, repair and fibrosis. Journal of innate immunity. 2012; 4 (5-6):463-77. doi: 10.1159/000336717 PMID: 22507825.
48. Ammon C, Meyer SP, Schwarzfischer L, Krause SW, Andreesen R, Kreutz M. Comparative analysis of integrin expression on monocyte-derived macrophages and monocyte-derived dendritic cells. Immunology. 2000; 100(3):364-9. Epub 2000/08/06. PMID: 10929059; PubMed Central PMCID: PMCPMC2327027.
49. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell. 2002; 111 (7):927-30. Epub 2003/01/01. PMID: 12507420.
50. Harris ES, Mc Intyre TM, Prescott SM, Zimmerman GA. The leukocyte integrins. J Biol Chem. 2000; 275(31):23409-12. PMID: 10801898
51. El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature. 1996; 382(6593):716-9. Epub 1996/08/22. doi: 10.1038/382716a0 PMID: 8751442.
52. Overall CM. Molecular determinants of metalloproteinase substrate specificity: matrix metalloprotei-nase substrate binding domains, modules, andexosites. Mol Biotechnol. 2002; 22(1):51-86. doi: 10. 1385/MB:22:1:051 PMID: 12353914.
53. Eckhard U, Huesgen PF, Schilling O, Bellac CL, Butler GS, Cox JH, et al. Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses. Matrix biology: journal of the International Society for Matrix Biology. 2015. doi: 10.1016/j.matbio.2015.09.003 PMID: 26407638.
54. Edosada CY, Quan C, Tran T, Pham V, Wiesmann C, Fairbrother W, et al. Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity. FEBS Lett. 2006; 580(6):1581-6. doi: 10.1016/j.febslet.2006.01.087 PMID: 16480718.
55. Greaves DR, Gordon S. The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges. J Lipid Res. 2009; 50 Suppl:S282-6. Epub 2008/12/17. doi: 10.1194/jlr. R800066-JLR200 PMID: 19074372; PubMed Central PMCID: PMC2674758.
56. Plüddemann A, Neyen C, Gordon S. Macrophage scavenger receptors and host-derived ligands. Methods. 2007; 43(3):207-17. doi: 10.1016/j.ymeth.2007.06.004 PMID: 17920517.
57. Ohtaki Y, Ishii G, Nagai K, Ashimine S, Kuwata T, Hishida T, et al. Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer. 2010; 5(10):1507-15. Epub 2010/08/31. doi: 10.1097/JTO.0b013e3181eba692 PMID: 20802348.
58. Yang G, Addai J, Tian WH, Frolov A, Wheeler TM, Thompson TC. Reduced infiltration of class A scavenger receptor positive antigen-presenting cells is associated with prostate cancer progression. Cancer Res. 2004; 64(6):2076-82. Epub 2004/03/18. PMID: 15026346.
59. Neyen C, Pluddemann A, Mukhopadhyay S, Maniati E, Bossard M, Gordon S, et al. Macrophage scavenger receptor a promotes tumor progression in murine models of ovarian and pancreatic cancer. J Immunol. 2013; 190(7):3798-805. Epub 2013/03/01. doi: 10.4049/jimmunol.1203194 PMID: 23447685; PubMed Central PMCID: PMCPMC3608578.
60. Nikolic DM, Vadali S, He B, Ware J, Kelly T, Post SR. Prostaglandins produced during class A scavenger receptor-mediated macrophage adhesion differentially regulate cytokine production. J Leukoc Biol. 2015; 97(5):901-8. doi: 10.1189/jlb.2A1014-471RR PMID: 25717147.
61. Haworth R, Platt N, Keshav S, Hughes D, Darley E, Suzuki H, et al. The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med. 1997; 186(9):1431-9. doi: 10.1084/Jem.186.9.1431 PMID: WOS:A1997YE94200003.
62. Cotena A, Gordon S, Platt N. The class A macrophage scavenger receptor attenuates CXCchemokine production and the early infiltration of neutrophils in sterile peritonitis. J Immunol. 2004; 173(10):6427-32. Epub 2004/11/06. PMID: 15528383.
63. Tsujita K, Kaikita K, Hayasaki T, Honda T, Kobayashi H, Sakashita N, et al. Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction. Circulation. 2007; 115(14):1904-11. Epub 2007/03/29. doi: 10.1161/CIRCULATIONAHA. 106.671198 PMID: 17389263.